Dr. Carlos Cervera, MD, PhD
Assistant Professor, Department of Medicine, University of Alberta
Medical Director, Transplant Infectious Diseases
Carlos Cervera received his MD from Autonomous University of Barcelona, Spain, in 1994. He completed residency in Hospital Vall d’Hebron receiving Spanish Board Certification in 2001. After his residency, he joined Hospital Clinic of Barcelona in 2003. He received his PhD for his work on innate immune receptors and post-transplant infections in 2010 from the Department of Medicine, University of Barcelona. Since 2003, Dr. Cervera has been working as infectious diseases specialist with a major focus in transplant infectious disease. In February 2015, he joined the Division of Infectious Diseases, Department of Medicine, at the University of Alberta (Canada).
Dr Cervera’s main research interests include infections in immunosuppressed patients and patients with solid organ transplantation. His doctoral thesis focused on the study of genetic polymorphisms in innate immune receptors and the risk of infections in solid organ transplant recipients. In the field of immunosuppression, he has acquired wide experience with infections related to the use of lymphocyte-depletion drugs, calcineurin inhibitors and mTOR inhibitors, and other immunosuppressants. Other areas of interest include fungal infections, microbiota and viral infections. He is member in good standing of the European Society of Clinical Microbiology and Infectious Diseases, American Society of Transplantation, Canadian Society of Transplantation and Infectious Diseases Society of America. He has authored more than 180 original articles in indexed journals and over 25 book chapters.
Carlos Cervera has been reviewer for numerous Journals that include Clinical Infectious Diseases, Journal of Infectious Diseases, Journal of Heart and Lung Transplantation, American Journal of Transplantation, Transplantation, Liver Transplantation, Transplant Infectious Disease, and others. He is the Medical Director of Transplant Infectious Diseases at the University of Alberta.